Kit ELISA CD200 sandwich (human): quantitative determination of Hu CD200 in serum, plasma or cell culture medium. The test recognizes only the natural and recombinant forms of Hu CD200.
Accession number
P41217
Dose range
24.58-6000 pg/ml
Sensitivity of the dosage
20 pg/ml
Calibration range
20 pg/ml to 6000 pg/ml
Dose
ELISA solid-phase sandwich
Brand
Invitrogen
Kit ELISA CD200 sandwich (human): quantitative determination of Hu CD200 in serum, plasma or cell culture medium. The test recognizes only the natural and recombinant forms of Hu CD200.
Kit ELISA CD200 sandwich (human): quantitative determination of Hu CD200 in serum, plasma or cell culture medium. The test recognizes only the natural and recombinant forms of Hu CD200.
Method principle: This ELISA solid phase sandwich test (immuno-enzymatic dose) measures the amount of target bound between a pair of matched antibodies. A specific target antibody is pre-adsorbed into the wells of the supplied microplate. Samples, standards or controls are added to these wells and bind to immobilized antibodies (capture antibodies). The sandwich is formed by adding the second antibody (detection antibody), then a substrate solution reacts with the enzyme-antibodies-target complex to produce a measurable signal. The intensity of this signal is directly proportional to the concentration of the target present in the original sample.
Rigorous validation: Each batch manufactured from this ELISA kit is checked for criteria such as sensitivity, specificity, accuracy and reproducibility from one batch to another (see the package leaflet for more information on validation).
CD200 is a type 1 membrane glycoprotein that contains two domains of immunoglobulin and belongs to the superfamily d-immunoglobulins. CD200 is a widely distributed cell surface glycoprotein that interacts with a myeloid cell receptor (CD200R) and is involved in the local prevention of macrophage activation. Remote but recognizable counterparts of CD200 have been identified in many herpesviruses and poxviruses. Studies of related genes in mice and rats suggest that CD200 can regulate myeloid cell activity and provide an inhibitory signal for the macrophage lineage in various tissues. Several spliced transcription variants that code different isoforms of CD200 have been found. Diseases associated with CD200 dysfunction include mantle cell lymphoma and primary hypertrophic osteoarthropathy.